Unknown

Dataset Information

Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS.


ABSTRACT: Sapitinib (AZD8931, SAP) is an epidermal growth factor receptor (EGFR) family (pan-erbB) tyrosine kinase inhibitor. In multiple tumor cell lines, SAP has been shown to be a much more potent inhibitor of EGF-driven cellular proliferation than gefitinib. In this in vitro metabolic study, we tested the generation of reactive intermediates from SAP using human liver microsomes and a capturing agent (potassium cyanide) to trap the iminium reactive intermediates. The same metabolic reaction was further repeated in the presence of methoxyamine to trap aldehyde intermediates. The identification of SAP metabolites revealed that the hydroxylation metabolic reaction represents the major in vitro metabolic pathway occurring at the piperidine moiety. We characterized six in vitro p

SUBMITTER: Attwa MW 

PROVIDER: S-EPMC9073192 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature